Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anamorelin for COPD-associated cachexia (prospective open-label study)
jRCTs031230446Recruiting
- Sponsor
- Chiba University Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of anamorelin in cachexia, sponsored by Chiba University Hospital. Primary endpoint: Lean body mass maintenance or increase at Day 85. Started May 2024; status: recruiting.
02
Drugs
anamorelin
03
Conditions
cachexia
Beyond the preview
Go deeper on jRCTs031230446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230446.